These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 35431911)
1. CD44-Targeted Nanocarrier for Cancer Therapy. Kesharwani P; Chadar R; Sheikh A; Rizg WY; Safhi AY Front Pharmacol; 2021; 12():800481. PubMed ID: 35431911 [TBL] [Abstract][Full Text] [Related]
2. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System. Yu T; Li Y; Gu X; Li Q Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. Mattheolabakis G; Milane L; Singh A; Amiji MM J Drug Target; 2015; 23(7-8):605-18. PubMed ID: 26453158 [TBL] [Abstract][Full Text] [Related]
5. Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment. Raval H; Bhattacharya S Curr Med Chem; 2024 Apr; ():. PubMed ID: 38571347 [TBL] [Abstract][Full Text] [Related]
6. Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate. Arpicco S; Bartkowski M; Barge A; Zonari D; Serpe L; Milla P; Dosio F; Stella B; Giordani S Front Chem; 2020; 8():578008. PubMed ID: 33381490 [TBL] [Abstract][Full Text] [Related]
7. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Platt VM; Szoka FC Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053 [TBL] [Abstract][Full Text] [Related]
8. Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy. Li M; Sun J; Zhang W; Zhao Y; Zhang S; Zhang S Carbohydr Polym; 2021 Jan; 251():117103. PubMed ID: 33142641 [TBL] [Abstract][Full Text] [Related]
9. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
10. Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation. Oommen OP; Duehrkop C; Nilsson B; Hilborn J; Varghese OP ACS Appl Mater Interfaces; 2016 Aug; 8(32):20614-24. PubMed ID: 27468113 [TBL] [Abstract][Full Text] [Related]
11. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake. Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864 [TBL] [Abstract][Full Text] [Related]
12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
13. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720 [TBL] [Abstract][Full Text] [Related]
14. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer. Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery. Fu CP; Cai XY; Chen SL; Yu HW; Fang Y; Feng XC; Zhang LM; Li CY Polymers (Basel); 2023 May; 15(10):. PubMed ID: 37242892 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK Biomacromolecules; 2015 Sep; 16(9):3042-53. PubMed ID: 26302089 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047 [No Abstract] [Full Text] [Related]
18. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
19. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery. Hang C; Zou Y; Zhong Y; Zhong Z; Meng F Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090 [TBL] [Abstract][Full Text] [Related]
20. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy. Zhao Y; Zhang T; Duan S; Davies NM; Forrest ML Nanomedicine; 2014 Aug; 10(6):1221-30. PubMed ID: 24637218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]